Management of bone metastasis and cancer treatment-induced bone loss during the COVID-19 pandemic: An international perspective and recommendations

Management of bone metastasis and cancer treatment-induced bone loss during the COVID-19 pandemic: An international perspective and recommendations

Optimum management of patients with cancer during the COVID-19 pandemic has proved extremely challenging. Patients, clinicians and hospital authorities have had to balance the risks to patients of attending hospital, many of whom are especially vulnerable, with the risks of delaying or modifying can...

Fuld beskrivelse

Bibliografiske detaljer
Main Authors:	Brown, JE, Wood, SL, Confavreux, C, Abe, M, Weilbaecher, K, Hadji, P, Johnson, RW, Rhoades, JA, Edwards, CM, Croucher, PI, Juarez, P, El Badri, S, Ariaspinilla, G, D'Oronzo, S, Guise, TA, Van Poznak, C
Format:	Journal article
Sprog:	English
Udgivet:	Elsevier 2021

Lignende værker

Management of bone metastasis and cancer treatment-induced bone loss during the COVID-19 pandemic: An international perspective and recommendations
af: J.E. Brown, et al.
Udgivet: (2021-08-01)

Metastatic bone disease: Pathogenesis and therapeutic options
af: Stella D'Oronzo, et al.
Udgivet: (2019-04-01)

Tumor-host cell interactions in the bone disease of myeloma.
af: Fowler, J, et al.
Udgivet: (2011)

Targeted RNA-seq signature of breast cancer (BC) circulating tumor cells (CTCs) correlates with the onset of bone-only metastases
af: Stella D'oronzo, et al.
Udgivet: (2021-04-01)

Application of “omics” sciences to the prediction of bone metastases from breast cancer: State of the art
af: Marica Gentile, et al.
Udgivet: (2021-02-01)

Combustion structures: is it a question of relationships?
af: Cosimo D’Oronzo
Udgivet: (2019-12-01)

Osteoprotegerin and the development of myeloma bone disease
af: Croucher, P, et al.
Udgivet: (2004)

Clinical disorders of bone resorption.
af: Russell, G, et al.
Udgivet: (2001)

Agonists of TRAIL death receptors induce myeloma cell apoptosis that is not prevented by cells of the bone marrow microenvironment.
af: Locklin, R, et al.
Udgivet: (2007)

Myeloma cells can down-regulate release of osteoprotegerin (OPG) from human bone cells - A contributing factor in myeloma bone loss?
af: Shipman, C, et al.
Udgivet: (2002)

Advances in the molecular pharmacology of bone and cancer-related bone diseases
af: Edwards, CM, et al.
Udgivet: (2021)

Bisphosphonates and osteoprotegerin as inhibitors of myeloma bone disease.
af: Croucher, P, et al.
Udgivet: (2003)

Bone marrow adipose tissue and cancer
af: Edwards, CM
Udgivet: (2020)

Editorial: Cancer and bone metastasis, volume II
af: Chandi C. Mandal, et al.
Udgivet: (2022-07-01)

Metabolism in the tumour-bone microenvironment
af: Whitburn, J, et al.
Udgivet: (2021)

Editorial: Bone cell differentiation in health and disease, volume II
af: Chandi C. Mandal, et al.
Udgivet: (2024-11-01)

Editorial - Cancer and Bone special issue
af: Edwards, CM, et al.
Udgivet: (2022)

The role of bone marrow adipocytes in bone metastasis
af: Edwards, C, et al.
Udgivet: (2016)

#23. Elucidating the role of bone marrow stiffness in estrogen signaling in metastatic breast cancer to the bone
af: Logan Northcutt, et al.
Udgivet: (2024-04-01)

Bone marrow endothelial cells produce osteoprotegerin: Evidence for a role in the development of myeloma bone disease
af: De Leenheer, E, et al.
Udgivet: (2004)

Psychotropic drugs and bone
af: R.W. Gasser, et al.
Udgivet: (2024-12-01)

The Role of TGF-β in Bone Metastases
af: Trupti Trivedi, et al.
Udgivet: (2021-11-01)

Morphogens and growth factor signalling in the myeloma bone-lining niche
af: Morris, EV, et al.
Udgivet: (2021)

Bone marrow endothelial cells express the osteoclastogenic factor RANKL and its decoy receptor OPG: Evidence for a role in the development of myeloma bone disease.
af: De Leenheer, E, et al.
Udgivet: (2002)

Cells of the bone marrow microenvironment protect myeloma cells from apoptosis induced by TRAIL but not by agonists of TRAIL death receptors.
af: Locklin, R, et al.
Udgivet: (2005)

Bone marrow adipose tissue: a new player in cancer metastasis to bone
af: Morris, E, et al.
Udgivet: (2016)

A mathematical model of bone remodeling dynamics for normal bone cell populations and myeloma bone disease.
af: Ayati, B, et al.
Udgivet: (2010)

A mathematical model of bone remodeling dynamics for normal bone cell populations and myeloma bone disease
af: Webb Glenn F, et al.
Udgivet: (2010-04-01)

Modeling the human bone–tumor niche: reducing and replacing the need for animal data
af: Rao, SR, et al.
Udgivet: (2020)

#17. Evolution of epidemiology of bone metastasis in France: A rising issue
af: M Belhassen, et al.
Udgivet: (2024-04-01)

The Bone Marrow Microenvironment in Multiple Myeloma
af: Edwards, C
Udgivet: (2010)

#46. cAMP-mediated acid signaling regulates tumor-myeloid-bone cell crosstalk in the bone-tumor microenvironment
af: Kaylee O'Donnell, et al.
Udgivet: (2024-04-01)

Aromatase inhibitor-associated bone loss and its management with bisphosphonates in patients with breast cancer
af: Bauer M, et al.
Udgivet: (2012-06-01)

Bone decalcification to assess programmed cell death ligand 1 expression in bone metastases of non-small cell lung cancers
af: Guillaume Pontarollo, et al.
Udgivet: (2020-04-01)

Genetic models of bone disease using ENU mutagenesis
af: Brown, S, et al.
Udgivet: (2009)

The role of bone marrow adipocytes in bone metastasis
af: Emma V. Morris, et al.
Udgivet: (2016-09-01)

Statins and bone: myth or reality?
af: Edwards, C, et al.
Udgivet: (2001)

Increasing Wnt signaling in the bone marrow microenvironment inhibits the development of myeloma bone disease and reduces tumor burden in bone in vivo.
af: Edwards, C, et al.
Udgivet: (2008)

#50. Investigating the role of EphA2 in breast cancer bone metastasis
af: Verra Ngwa, et al.
Udgivet: (2024-04-01)

Wnt signaling: bone's defense against myeloma.
af: Edwards, C
Udgivet: (2008)